Cargando…
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Urinary bladder cancer is a common malignancy, being characterized by substantial patient mortality and management cost. Its high somatic-mutation frequency and molecular heterogeneity usually renders tumors refractory to the applied regimens. Hitherto, methotrexate-vinblastine-adriamycin-cisplatin...
Autores principales: | Giannopoulou, Aikaterini F., Velentzas, Athanassios D., Konstantakou, Eumorphia G., Avgeris, Margaritis, Katarachia, Stamatia A., Papandreou, Nikos C., Kalavros, Nikolas I., Mpakou, Vassiliki E., Iconomidou, Vassiliki, Anastasiadou, Ema, Kostakis, Ioannis K., Papassideri, Issidora S., Voutsinas, Gerassimos E., Scorilas, Andreas, Stravopodis, Dimitrios J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471041/ https://www.ncbi.nlm.nih.gov/pubmed/30875794 http://dx.doi.org/10.3390/ijms20061291 |
Ejemplares similares
-
Targeting of copper-trafficking chaperones causes gene-specific systemic pathology in Drosophila melanogaster: prospective expansion of mutational landscapes that regulate tumor resistance to cisplatin
por: Theotoki, Eleni I., et al.
Publicado: (2019) -
Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients
por: Giannopoulou, Aikaterini F., et al.
Publicado: (2019) -
Data of sperm-entry inability in Drosophila melanogaster ovarian follicles that are depleted of s36 chorionic protein
por: Velentzas, Athanassios D., et al.
Publicado: (2017) -
From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis
por: Giannopoulou, Aikaterini F., et al.
Publicado: (2021) -
Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers
por: Iliou, Aikaterini, et al.
Publicado: (2020)